Citation Impact
Citing Papers
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
2010
Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression
2011
Triple-negative breast cancer: is there a treatment on the horizon?
2016
CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
2016
Breast cancer
2019 Standout
Ferroptosis: past, present and future
2020 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
2012
Clinical management of adrenocortical carcinoma
2009
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Ovarian cancer
2014 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome
2006
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Cardiotoxicity of Chemotherapeutic Agents
2000
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
2018
Endothelial cell effects of cytotoxics: balance between desired and unwanted effects
2004
Epirubicin
1993
Pyroptosis: A new frontier in cancer
2019 Standout
Constructive and unconstructive repetitive thought.
2008 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
2000
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Allogeneic tumor cell vaccines
2013
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Ruminative Response Styles and Delay of Seeking Diagnosis for Breast Cancer Symptoms
2006
Update in Adrenocortical Carcinoma
2013
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway
2017
Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
2018
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Rethinking Rumination
2008 Standout
Vascular toxicity associated with antineoplastic agents.
1986
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells
1986 StandoutNobel
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
1984
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Cardiovascular Complications of Cancer Therapy
2004
Works of Reinaldo Chacón being referenced
Triple-negative breast cancer
2010
A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients
2006
Cardiovascular autonomic function in anthracycline-treated breast cancer patients
1990
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer
2009
Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer
2002
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
2012
Relation between Delay and Survival in 596 Patients with Breast Cancer
1989
Phase II Trial of 4′-Epi-Doxorubicin in Locally Advanced or Metastatic Gastric Cancer
1988
Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC): A meta-analysis of published data
2007
CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide.
2005
Dramatic Responses to Therapy in Rare Tumors
2005
Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate.
1981
Vinca alkaloid-induced cardiovascular autonomic neuropathy.
1985